P3 Health Partners FY2025 operating loss narrows to $270 million; revenue drops 2.8% to $1.46 billion

Reuters03-27

P3 Health Partners FY2025 operating loss narrows to $270 million; revenue drops 2.8% to $1.46 billion

P3 Health published an earnings release reporting fourth-quarter and full-year 2025 results and issuing 2026 guidance.
Fourth-quarter revenue rose 3.81% to USD 384.8 million, while at-risk membership fell 9% to about 115,000.
Medical margin was negative USD 28.7 million and adjusted EBITDA loss was USD 76.1 million.
Full-year revenue fell 2.76% to USD 1.46 billion, while at-risk membership fell 8% to about 116,000 driven by intentional network alignment.
For 2026, P3 expects adjusted EBITDA of negative USD 20 million to positive USD 40 million, with CEO Aric Coffman citing improved contract economics and provider alignment and projecting about USD 170 million of year-over-year EBITDA improvement at the midpoint.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. P3 Health Partners Inc. published the original content used to generate this news brief on March 26, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622896153?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 04:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622896153","market":"us","top_or_hot":-1,"title":"P3 Health Partners FY2025 operating loss narrows to $270 million; revenue drops 2.8% to $1.46 billion","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      P3 Health Partners FY2025 operating loss narrows to $270 million; revenue drops 2.8% to $1.46 billion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          P3 Health published an earnings release reporting fourth-quarter and full-year 2025 results and issuing 2026 guidance.\n        </li>\n<li>\n          Fourth-quarter revenue rose 3.81% to USD 384.8 million, while at-risk membership fell 9% to about 115,000.\n        </li>\n<li>\n          Medical margin was negative USD 28.7 million and adjusted EBITDA loss was USD 76.1 million.\n        </li>\n<li>\n          Full-year revenue fell 2.76% to USD 1.46 billion, while at-risk membership fell 8% to about 116,000 driven by intentional network alignment.\n        </li>\n<li>\n          For 2026, P3 expects adjusted EBITDA of negative USD 20 million to positive USD 40 million, with CEO Aric Coffman citing improved contract economics and provider alignment and projecting about USD 170 million of year-over-year EBITDA improvement at the midpoint.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. P3 Health Partners Inc. published the original content used to generate this news brief on March 26, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>P3 Health Partners FY2025 operating loss narrows to $270 million; revenue drops 2.8% to $1.46 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nP3 Health Partners FY2025 operating loss narrows to $270 million; revenue drops 2.8% to $1.46 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-27 04:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      P3 Health Partners FY2025 operating loss narrows to $270 million; revenue drops 2.8% to $1.46 billion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          P3 Health published an earnings release reporting fourth-quarter and full-year 2025 results and issuing 2026 guidance.\n        </li>\n<li>\n          Fourth-quarter revenue rose 3.81% to USD 384.8 million, while at-risk membership fell 9% to about 115,000.\n        </li>\n<li>\n          Medical margin was negative USD 28.7 million and adjusted EBITDA loss was USD 76.1 million.\n        </li>\n<li>\n          Full-year revenue fell 2.76% to USD 1.46 billion, while at-risk membership fell 8% to about 116,000 driven by intentional network alignment.\n        </li>\n<li>\n          For 2026, P3 expects adjusted EBITDA of negative USD 20 million to positive USD 40 million, with CEO Aric Coffman citing improved contract economics and provider alignment and projecting about USD 170 million of year-over-year EBITDA improvement at the midpoint.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. P3 Health Partners Inc. published the original content used to generate this news brief on March 26, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PIII","symbol_name":"3 Health Partners","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL4J1PW6:1","article_id":"2622896153","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622896153","pubTimestamp":1774555581,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"P3 Health published an earnings release reporting fourth-quarter and full-year 2025 results and issuing 2026 guidance.Fourth-quarter revenue rose 3.81% to USD 384.8 million, while at-risk membership fell 9% to about 115,000.Medical margin was negative USD 28.7 million and adjusted EBITDA loss was USD 76.1 million.Full-year revenue fell 2.76% to USD 1.46 billion, while at-risk membership fell 8% to about 116,000 driven by intentional network alignment.For 2026, P3 expects adjusted EBITDA of negative USD 20 million to positive USD 40 million, with CEO Aric Coffman citing improved contract economics and provider alignment and projecting about USD 170 million of year-over-year EBITDA improvement at the midpoint.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PIII":"3 Health Partners","BK4196":"保健护理服务"},"translate_title":"P3 Health Partners 2025财年运营亏损收窄至2.7亿美元；收入下降2.8%至14.6亿美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PIII":0.9},"content_text":"P3 Health Partners FY2025 operating loss narrows to $270 million; revenue drops 2.8% to $1.46 billion\n    \n\n\n          P3 Health published an earnings release reporting fourth-quarter and full-year 2025 results and issuing 2026 guidance.\n        \n\n          Fourth-quarter revenue rose 3.81% to USD 384.8 million, while at-risk membership fell 9% to about 115,000.\n        \n\n          Medical margin was negative USD 28.7 million and adjusted EBITDA loss was USD 76.1 million.\n        \n\n          Full-year revenue fell 2.76% to USD 1.46 billion, while at-risk membership fell 8% to about 116,000 driven by intentional network alignment.\n        \n\n          For 2026, P3 expects adjusted EBITDA of negative USD 20 million to positive USD 40 million, with CEO Aric Coffman citing improved contract economics and provider alignment and projecting about USD 170 million of year-over-year EBITDA improvement at the midpoint.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. P3 Health Partners Inc. published the original content used to generate this news brief on March 26, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622896153","isCrawlerRequest":true}